Skip to content
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
The COVID-19 pandemic laid bare the vulnerabilities of global supply chains, especially in the biopharmaceutical sector. “Nobody ever could have envisioned a global pandemic […]
Why building America’s biomanufacturing sector is critical for America’s security Read More »
Innovative companies using biotechnology to make renewable raw materials can enable more sustainable, climate-friendly manufacturing while providing an additional source of income for farmers.
BIO calls for legislation to boost biomanufacturing Read More »
President Biden delivered his third State of the Union address last night, March 7. Health care was a prominent theme throughout the night, which
Key takeaways from the State of the Union address Read More »
The World Trade Organization (WTO) 13th Ministerial concluded on Friday, March 1, without an agreement to expand the COVID-19 intellectual property waiver to therapeutics
WTO Ministerial ends, no expansion of COVID IP waiver Read More »
On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome
As White House prepares ‘listening session’ on PBMs, here’s what they need to hear Read More »
Biotechnology Innovation Organization (BIO) member companies and CEOs sent a letter to congressional leaders urging them to pass the bipartisan ORPHAN Cures Act and
CEOs ask Congress to pass ORPHAN Cures Act Read More »
As the 13th Ministerial Conference of the World Trade Organization (WTO) kicks off (Feb. 26-29), the expansion of the COVID-19 IP waiver remains a
Why the WTO should focus on addressing trade-related aspects of pandemic preparedness Read More »
On February 13, the New Mexico legislature passed a clean fuel standard—which the Biotechnology Innovation Organization (BIO) has long advocated for. The Clean Transportation
New Mexico legislature passes clean fuel standard Read More »
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process
BIO comments on NIST proposal to use march-in rights for price controls Read More »
The U.S. Trade Representative (USTR) needs to call out worldwide intellectual property deficiencies that harm U.S. biotech innovation—and they must not support a proposed
BIO report to USTR on global IP threats warns against TRIPS waiver Read More »
